Skip to content

Randomised, crossover bioequivalence clinical trial of montelukast 10 mg capsules vs montelukast 10 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions.

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-506937-30-00
Acronym
UECHUP-MON/23-4
Enrollment
36
Registered
2023-09-04
Start date
2023-09-20
Completion date
2023-10-16
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

None listed

Sponsors

Laboratorios Alter S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026